French drugmaker Sanofi-Aventis said Tuesday that it is considering a plan for voluntary staff departures. The firm will not be laying off staff, it said as it outlined a new R&D model under which it will combine its discovery research establishments in France.
Preclinical activities in some sites of Spain, the United Kingdom, the United States and Japan will also be reorganized, with divestment or reconversion solutions sought for certain activities. The firm is also reevaluating the resources needed for central group functions located in the Paris area.
Source
No comments:
Post a Comment